Internal Medicine & Geriatrics

Projects

Projects per year 2009 2013 2015 2017 2018 2019 2022 2026

• 4 Active
• 48 Finished

Projects per year

Search results

• Active

  Impact of Vimient Connect Serv

  Camp, K. (PI), Murphy, S. (CoI) & Nguyen, U.-S. (CoI)

  Vimient

  1/04/24 → 1/04/26

  Project: Research

• Home-based heat therapy to improve functional capacity and vascular health in older adults

  Romero, S. (PI), Yurvati, A. (CoI), Kline, G. (CoI) & Garfield, T. (CoI)

  American Heart Association

  1/07/22 → 30/06/25

  Project: Research

• Intermittent Hypoxia Training: A Novel Therapy for Mild Cognitive Impairment

  Shi, X. (PI), Mallet, R. (CoI), Kline, G. (CoI), Wiechmann, A. (CoI), Ross, S. (CoI), Zhou, Z. (CoI) & Davis, S. (CoI)

  NIA: National Institute on Aging

  1/05/22 → 30/04/25

  Project: Research

• AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With

  Johnson, L. (PI) & Davis, S. (CoI)

  University of Southern California

  1/01/20 → 31/12/24

  Project: Research

• Finished

  HHSC No Wrong Door System Surv

  Murphy, S. (PI), Severance, J. (CoI) & Yockey, A. (CoI)

  TX Health and Human Services Commission

  2/09/22 → 1/09/24

  Project: Research

• Assessing Barriers and Factors to Cancer Care among LGBT Older Adults

  Yockey, A. (PI) & Garfield, T. (CoI)

  University of Texas Medical Branch at

  31/08/22 → 30/08/23

  Project: Research

• Assessing Performance on a Digital Cognitive Health Solution Among Older Adults of Varying Levels of Cognitive Impairment

  Wiechmann, A. (PI) & Harty, B. (CoI)

  Texas A&M University - College Station

  1/05/22 → 30/04/23

  Project: Research

• Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease

  Johnson, L. (PI), Large, S. (CoI) & Davis, S. (CoI)

  University of Southern California

  1/05/20 → 30/04/23

  Project: Research

• The A45 Study: Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease

  Johnson, L. (PI) & Davis, S. (CoI)

  University of Southern California

  30/09/19 → 31/05/21

  Project: Research

• Geriatric Academic Career Award (GACA)

  Camp, K. (PI)

  Health Resources & Service Administratio

  1/09/19 → 31/08/23

  Project: Research

• Geriatrics Workforce Enhancement Program - Supplement

  Knebl, J. (PI) & Ross, S. (CoI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• Workforce Enhancement in Healthy Aging and Independent Living

  Knebl, J. (PI) & Ross, S. (CoI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• Workforce Enhancement in Healthy Aging and Independent Living

  Knebl, J. (PI), Harty, B. (CoI) & Ross, S. (CoI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• Collective Action to Drive Systems-Level Change

  Severance, J. (PI) & Knebl, J. (CoI)

  United Way of Tarrant County

  1/07/19 → 30/06/20

  Project: Research

• Workforce Enhancement in Healthy Aging and Independent Living

  Knebl, J. (PI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• Workforce Enhancement in Healthy Aging and Independent Living

  Knebl, J. (PI), Severance, J. (CoI), Love, B. (CoI), Murphy, S. (CoI), Camp, K. (CoI) & Hadley, L. (CoI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• Workforce Enhancement in Healthy Aging and Independent Living

  Knebl, J. (PI), Fairchild, T. (CoI), Severance, J. (CoI), Camp, K. (CoI), Hadley, L. (CoI) & Agena, V. (CoI)

  Health Resources & Service Administratio

  1/07/19 → 30/06/24

  Project: Research

• The A3 Study: Ante-Amyloid Pre

  Johnson, L. (PI), Large, S. (CoI) & Davis, S. (CoI)

  University of Southern California

  1/06/19 → 30/04/24

  Project: Research

• BN4003 l Version 2, entitled "A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE ill STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER'S DISEASE

  Knebl, J. (PI)

  Roche Diagnostics Corporation

  30/11/18 → 30/11/21

  Project: Research

• Detection of Elder Abuse Through Emergency Care Technicians (DETECT)

  O'Bryant, S. (PI), Zhang, F. (CoI) & Davis, S. (CoI)

  University of Texas HSC at Houston

  15/09/18 → 31/05/23

  Project: Research

• Assessing the Utility and Effectiveness of Dementia Patient Monitoring Technology

  Reuter, K. (PI) & Knebl, J. (CoI)

  Texas A&M Health Science Center

  22/08/18 → 31/08/20

  Project: Research

• Collective Action to Drive Systems-Level Change

  Severance, J. (PI) & Knebl, J. (CoI)

  United Way of Tarrant County

  1/07/18 → 30/06/19

  Project: Research

• ALZHEIMER¿S DISEASE- DONEPEZIL HYDROCHLORIDE AND MEMANTINE HYDROCHLORIDE

  Knebl, J. (PI)

  Merck Co.

  31/05/18 → 31/05/21

  Project: Research

• HRSA GWEP Small Networking Meetings

  Knebl, J. (PI) & Severance, J. (CoI)

  American Geriatrics Society

  1/09/17 → 31/12/17

  Project: Research

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

  Kline, G. (PI)

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

  Kline, G. (PI)

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES

  Kline, G. (PI)

  Kowa Research Institute, Inc.

  31/03/17 → 31/03/21

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant

  Kline, G. (PI)

  Esperion Therapeutics, Inc.

  13/02/17 → 13/02/21

  Project: Research

• Opportunities for Peer Models of Health Promotion in Senior Centers: An Exploratory Study

  Severance, J. (PI)

  Intramural Research(UNTHSC)

  1/01/17 → 31/12/17

  Project: Research

• An Interprofessional Approach to Patient Safety Improvement in Skilled Nursing Facilities

  Ross, S. (PI)

  Intramural Research(UNTHSC)

  1/01/17 → 30/06/18

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)

  Knebl, J. (PI)

  Eli Lilly

  13/10/16 → 12/10/21

  Project: Research

• "A PHASE Ill, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER'S DISEASE"

  Knebl, J. (PI)

  Hoffmann-La Roche Inc.

  18/08/16 → 17/08/21

  Project: Research

• Opioid Supplement

  Knebl, J. (PI)

  Health Resources & Service Administratio

  1/07/15 → 30/06/19

  Project: Research

• Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)

  Knebl, J. (PI), Fairchild, T. (CoI), Severance, J. (CoI), Fulda, K. (CoI), Ross, S. (CoI) & Bugnariu, N. (CoI)

  Health Resources & Service Administratio

  1/07/15 → 30/06/19

  Project: Research

• Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)

  Knebl, J. (PI) & Ross, S. (CoI)

  Health Resources & Service Administratio

  1/07/15 → 30/06/19

  Project: Research

• A Long-term Outcomes Study to Assess Statin Residual Risk Reduction with EpaNova High Cardiovascular Risk Patients witgh Hypertriglyceridemia (STRENGTH)

  Kline, G. (PI)

  Astra Zeneca

  8/06/15 → 30/06/24

  Project: Research

• An open-label extension study to evaluate the long-term safety and tolerability of Lu AE58054 as adjunctive treatment to donepezil in patients with mild-moderate Alzheimer¿s disease

  Knebl, J. (PI)

  Lundbeck Pharmaceuticals

  3/04/15 → 30/04/20

  Project: Research

• A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events

  Kline, G. (PI)

  Pfizer, Inc.

  17/03/15 → 31/03/20

  Project: Research

• Randomized, Double-blind, Parallel Group, Placebo-controlled, Fixed-dose of Lu AE58054 In Patients with Mild - Moderate Alzheimer's Disease Treated with Donepazil; Study 2

  Knebl, J. (PI)

  Lundbeck Pharmaceuticals

  8/12/14 → 31/12/19

  Project: Research

• A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer¿s Disease Therapy in Patients with Moderate Severity Alzheimer¿s Disease

  Knebl, J. (PI)

  Hoffmann-La Roche Inc.

  25/10/13 → 31/03/19

  Project: Research

• Tuberculosis Trials Consortium

  Weis, S. (PI)

  Centers for Disease Control

  18/09/13 → 17/09/14

  Project: Research

• Discharge Planning and Care Coordinated with Medicaid Eligible Elders with TCOM Student Danielle Ortega

  Knebl, J. (PI)

  Intramural Research(UNTHSC)

  1/09/13 → 31/08/14

  Project: Research

• Reynolds Interprofessional Geriatrics Education and Training in Texas (/GET-IT) Program

  Knebl, J. (PI)

  Donald W. Reynolds Foundation

  1/07/13 → 30/06/17

  Project: Research

• Discharge Planning and Care Coordination for Medicaid Eligible Elders

  Knebl, J. (PI), Bugnariu, N. (CoI) & O'Bryant, S. (CoI)

  Centers for Medicare & Medicaid Services

  1/06/13 → 31/12/17

  Project: Research

• A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome

  Kline, G. (PI)

  Sanofi Pasteur, Inc.

  31/01/13 → 30/01/20

  Project: Research

• Tuberculosis Trials Consortium

  Weis, S. (PI)

  Centers for Disease Control

  18/09/12 → 17/09/13

  Project: Research

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E ¿4 Non-Carriers

  Knebl, J. (PI)

  Pfizer, Inc.

  14/11/11 → 30/11/15

  Project: Research

• The Texas Consortium Geriatrics Education Center

  Knebl, J. (PI)

  Baylor College of Medicine

  1/07/10 → 30/06/15

  Project: Research

• A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (ABB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727-301 or in Study ELN115727-302

  Knebl, J. (PI)

  Janssen Pharmaceuticals

  4/05/10 → 31/12/13

  Project: Research

• Tuberculosis Trials Consortium

  Weis, S. (PI)

  Centers for Disease Control

  18/09/09 → 17/09/19

  Project: Research